Covid research: Convalescent plasma trial paused as results poor

Scientists running the REMAP-CAP trial, led by Imperial College London, have stopped enrolling Covid ICU patients after finding 'no evidence' convalescent plasma boosted survival rates.

from Health News | Mail Online https://ift.tt/38ymmTZ